Andreas Halvorsen – BBIO history
- Issuer:
- BRIDGEBIO PHARMA INC
- Quarters tracked:
- 24 (Q1 2021 → Q1 2026)
- Current shares:
- 11,842,434
- Current value:
- $879.42M
- Peak shares:
- 26,620,991 (Q1 2021)
- Overall change:
- -56%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 11,842,434 | $879.42M | $74.26 | -2,551,500 | -18% |
| Q4 2025 | 14,393,934 | $1.10B | $76.49 | -1,583,915 | -10% |
| Q3 2025 | 15,977,849 | $829.89M | $51.94 | -2,577,526 | -14% |
| Q2 2025 | 18,555,375 | $801.22B | $43180.00 | 0 | 0% |
| Q2 2025 | 18,555,375 | $801.22M | $43.18 | -3,500,000 | -16% |
| Q1 2025 | 22,055,375 | $762.45M | $34.57 | 0 | 0% |
| Q1 2025 | 22,055,375 | $762.45B | $34570.00 | -3,065,616 | -12% |
| Q4 2024 | 25,120,991 | $689.32M | $27.44 | 0 | 0% |
| Q4 2024 | 25,120,991 | $689.32B | $27440.00 | 0 | 0% |
| Q3 2024 | 25,120,991 | $639.58M | $25.46 | 0 | 0% |
| Q2 2024 | 25,120,991 | $636.32M | $25.33 | 0 | 0% |
| Q1 2024 | 25,120,991 | $776.74M | $30.92 | 0 | 0% |
| Q4 2023 | 25,120,991 | $1014.13B | $40370.00 | 0 | 0% |
| Q3 2023 | 25,120,991 | $662.44B | $26370.00 | -1,500,000 | -6% |
| Q2 2023 | 26,620,991 | $457.88B | $17200.00 | 0 | 0% |
| Q1 2023 | 26,620,991 | $441.38B | $16580.00 | 0 | 0% |
| Q4 2022 | 26,620,991 | $202.85M | $7.62 | 0 | 0% |
| Q3 2022 | 26,620,991 | $264.61M | $9.94 | 0 | 0% |
| Q2 2022 | 26,620,991 | $241.72M | $9.08 | 0 | 0% |
| Q1 2022 | 26,620,991 | $270.20M | $10.15 | 0 | 0% |
| Q4 2021 | 26,620,991 | $444.04M | $16.68 | 0 | 0% |
| Q3 2021 | 26,620,991 | $1.25B | $46.87 | 0 | 0% |
| Q2 2021 | 26,620,991 | $1.62B | $60.96 | 0 | 0% |
| Q1 2021 | 26,620,991 | $1.64B | $61.60 | — | NEW |